Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury
Rashid Kazerooni1, Mark Bounthavong1,21Pharmacoeconomics/Formulary Management, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA; 2UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USAObjective: There has been growing interest in newer anti-epileptic drugs (AE...
Main Authors: | Rashid Kazerooni, Mark Bounthavong |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/cost-effectiveness-analysis-of-intravenous-levetiracetam-versus-intrav-a4039 |
Similar Items
-
Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
by: BATOOL F. KIRMANI, et al.
Published: (2013-11-01) -
Comparison of levetiracetam versus phenytoin for seizure prophylaxis in
patients with traumatic brain injury: A meta-analysis
by: Ali Meshkini, et al.
Published: (2015-06-01) -
Role of Intravenous Levetiracetam in Acute Seizure Management
by: BATOOL F. KIRMANI
Published: (2014-06-01) -
Role of Intravenous Levetiracetam in Acute Seizure Management
Published: (2014) -
Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures
by: Yun-Jeong Lee, et al.
Published: (2016-01-01)